Hemocellular Development Corp is categorized under Management Services in Chapel Hill, NC and active since 2010.
Hemocellular Development Corp was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Management Services business, which does work in the B2B market, and is classified as a Management Services, under code number 561110 by the NAICS.
If you are seeking more information, feel free to contact Richard A Basile at the company’s single location by writing to 5312 Farrington Road, Chapel Hill, North Carolina NC 27517 or by phoning (919) 419-3169. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hemocellular Development Corp |
| Contact Person: | Richard A Basile |
| Address: | 5312 Farrington Road, Chapel Hill, North Carolina 27517 |
| Phone Number: | (919) 419-3169 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Management Services |
| SIC Code: | 8741 |
| NAICS Code: | 561110 |
| Share This Business: |
Hemocellular Development Corp was started in 2010 to provide professional Management Services under the SIC code 8741 and NAICS code 561110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Richard A Basile for inquiries that concern Hemocellular Development Corp by calling the company number (919) 419-3169, as your correspondence is most welcome. Additionally, the physical location of the single location of Hemocellular Development Corp can be found at the coordinates as well as the street address 5312 Farrington Road in Chapel Hill, North Carolina 27517.
For its online presence, you may visit Hemocellular Development Corp’s website at and engage with its social media outlets through on Twitter and on Facebook.